Lobbying client
IPIERIAN, INC.
iPierian is a biotech company utilizing cellular reprogramming for drug discovery
Filings
5
Filed by
1
Reported in-house
—
Reported by firms
$130,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2010 to 2011
Filings
3 filings for 2011, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination Amendment 2nd Quarter 2011
|
FABIANI & COMPANY | $50,000 reported |
|
2nd Quarter - Reportreplaced 2nd Quarter 2011
|
FABIANI & COMPANY | $50,000 reported |
|
1st Quarter - Report 1st Quarter 2011
|
FABIANI & COMPANY | $50,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| FABIANI & COMPANY | 3 | $130,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Veterans | VET | 4 |
| Health Issues | HCR | 4 |
| Defense | DEF | 4 |
| Medical/Disease Research/Clinical Labs | MED | 4 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.